Delving into the Latest Updates on Guangxi Golden Throat Co. Ltd. with Synapse

Overview

Tags

Otorhinolaryngologic Diseases

Respiratory Diseases

Mouth and Tooth Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Herbal medicine	1

A high performance liquid chromatog. (HPLC) method was developed for the rapid determination of Basic Yellow II in aquatic products by HPLC.Methods After being extracted by methanol homogenizer, the sample was rapidly separated by ODS-C₁₈ column (4.6mm×250mm, 5MM) and then detected by UV detector at 432nm.Results The linear relationship of Basic YellowII in aquatic products was good in the range of 0.02∼2mg·L^-1 (r²≥0.999), the average recovery was between 93.6% and 103.0%, the relative standard deviations (RS-DS) was less than 10%, and the limit of detection (LODs) was 0.004mg·kg^-1, the limitation of Quant. (LOQs) is 0.016mg·kg^-1.Conclusion The method is accurate and sensitive, and can be used for the rapid determination of Basic Yellow II in aquatic products.

100 Deals associated with Guangxi Golden Throat Co. Ltd.

Login to view more data

100 Translational Medicine associated with Guangxi Golden Throat Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data